Cargando…
Bafilomycin A1 inhibits SARS-CoV-2 infection in a human lung xenograft mouse model
Coronavirus disease 2019 is a global pandemic caused by SARS-CoV-2. The emergence of its variant strains has posed a considerable challenge to clinical treatment. Therefore, drugs capable of inhibiting SARS-CoV-2 infection, regardless of virus variations, are in urgently need. Our results showed tha...
Autores principales: | Zhang, Cuiling, Wei, Bingjie, Liu, Zirui, Yao, Wei, Li, Yiquan, Lu, Jing, Ge, Chenchen, Yu, Xiaoyang, Li, Dapeng, Zhu, Yilong, Shang, Chao, Jin, Ningyi, Li, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887234/ https://www.ncbi.nlm.nih.gov/pubmed/36721152 http://dx.doi.org/10.1186/s12985-023-01971-x |
Ejemplares similares
-
SARS-CoV-2 Causes Mitochondrial Dysfunction and Mitophagy Impairment
por: Shang, Chao, et al.
Publicado: (2022) -
Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues
por: Shang, Chao, et al.
Publicado: (2021) -
Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice
por: Shang, Chao, et al.
Publicado: (2021) -
Ad-VT enhances the sensitivity of chemotherapy-resistant lung adenocarcinoma cells to gemcitabine and paclitaxel in vitro and in vivo
por: Song, Gaojie, et al.
Publicado: (2022) -
Molecular basis of V-ATPase inhibition by bafilomycin A1
por: Wang, Rong, et al.
Publicado: (2021)